Market Surge: Mullen Gains Momentum, Pfizer's Investment Fuels Caribou Biosciences
- July 06th, 2023
- 627 views
Shares of Mullen Automotive, Inc. (Nasdaq: MULN) surged over 60% in pre-market trading after the company announced a $25 million stock buyback program authorized through December 31, 2023.
Mullen believes that its stock is significantly undervalued and trading at a substantial discount compared to its cash position of approximately $235 million.
In pre-market, $MULN is trading at $0.27, reflecting a notable increase of $0.10 (63.25%) following the announcement.
In other news, Caribou Biosciences, Inc. (Nasdaq: CRBU) has announced that Pfizer Inc. (NYSE: PFE) has invested $25 million in the company, purchasing 4,690,431 of its common shares at a price of $5.33 per share.
Caribou views Pfizer's investment as a validation of the potential of its clinical programs.
$CRBU is currently trading at $5.58 in pre-market, up $1.50 (36.76%).
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Post Your Comments
Want To Find Some News?
Recent Posts
-
October 29th, 2026
Treasury Sanctions Facilitators of DPRK IT Worker Fraud Targeting U.S. Businesses
October 28th, 2026Treasury Sanctions Rwandan Ministry of Defence and Financial Institution Supporting M23
October 28th, 2026October 26th, 2026FAA Releases Draft Design Standards for Vertical Flight Facilities
October 22nd, 2026
Member Login